Please cite:
Dimitra Karagkouni, Maria D. Paraskevopoulou, Serafeim Chatzopoulos, Ioannis S. Vlachos, Spyros Tastsoglou, Ilias Kanellos, Dimitris Papadimitriou, Ioannis Kavakiotis, Sofia Maniou, Giorgos Skoufos, Thanasis Vergoulis, Theodore Dalamagas, Artemis G. Hatzigeorgiou; DIANA-TarBase v8: a decade-long collection of experimentally supported miRNA–gene interactions, Nucleic Acids Research, gkx1141, https://doi.org/10.1093/nar/gkx1141
Bulk download:
We have updated the bulk download module, which simplifies the download process! Please find the new online form by following this link

hsa-let-7b-3p


Loading... Please wait, this might take a few seconds...



Filters
Interactions: 400, Experiments: (low: , high: , unknown: ) Cell lines: , Tissues: , Publications:
Gene name miRNA name Experiments
throughput
Publications Cell lines Tissues Pred. Score
MYC hsa-let-7b-3p low: 4 high: 1 1 2 2 -
Low-throughput experiments (4 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Braun J et al. 2014 RP Bone U2OS U2OS N/A
Location Method Result Regulation Validation Type Source
chr8:127740982-127741405 Luciferase Reporter Assay POSITIVE DIRECT TarBase 7.0
Braun J et al. 2014 WB qP Bone U2OS N/A N/A
Location Method Result Regulation Validation Type Source
UNKNOWN Western Blot POSITIVE INDIRECT TarBase 7.0
UNKNOWN qPCR POSITIVE INDIRECT TarBase 7.0
Braun J et al. 2014 RP Kidney HEK293 HEK293 N/A
Location Method Result Regulation Validation Type Source
chr8:127740982-127741405 Luciferase Reporter Assay POSITIVE DIRECT TarBase 7.0
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Braun J et al. 2014 TR Bone U2OS N/A N/A
Location Method Result Regulation Validation Type Source
UNKNOWN TRAP POSITIVE INDIRECT TarBase 7.0
ARID5B hsa-let-7b-3p low: 0 high: 5 3 4 3 0.940
High-throughput experiments (5 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr10:62096668-62096686 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Pillai MM et al. 2014 IP Mammary Gland BT474 N/A N/A
Location Method Result Regulation Validation Type Source
chr10:62096668-62096686 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr10:62093558-62093564 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Bone Marrow HS5 N/A N/A
Location Method Result Regulation Validation Type Source
chr10:62093558-62093564 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Bone Marrow HMSC N/A N/A
Location Method Result Regulation Validation Type Source
chr10:62096668-62096686 HITS-CLIP POSITIVE DIRECT TarBase 7.0
TAOK1 hsa-let-7b-3p low: 0 high: 4 2 2 2 0.989
High-throughput experiments (4 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr17:29551748-29551756 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr17:29546719-29546741 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Pillai MM et al. 2014 IP Mammary Gland BT474 N/A N/A
Location Method Result Regulation Validation Type Source
chr17:29551748-29551756 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr17:29550288-29550294 HITS-CLIP POSITIVE DIRECT TarBase 7.0
PUM2 hsa-let-7b-3p low: 0 high: 3 3 3 3 -
High-throughput experiments (3 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr2:20250463-20250487 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Pillai MM et al. 2014 IP Mammary Gland BT474 N/A N/A
Location Method Result Regulation Validation Type Source
chr2:20250463-20250487 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Bone Marrow HS5 N/A N/A
Location Method Result Regulation Validation Type Source
chr2:20250339-20250363 HITS-CLIP POSITIVE DIRECT TarBase 7.0
GSK3B hsa-let-7b-3p low: 0 high: 2 3 3 3 0.963
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr3:119822225-119822244 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Pillai MM et al. 2014 IP Mammary Gland BT474 N/A N/A
Location Method Result Regulation Validation Type Source
chr3:119823969-119823985 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Other Databases
Publication Methods Tissue Cell line Tested cell line Exp. condition
Hafner M. et al. 2010 O N/A N/A N/A N/A
Location Method Result Regulation Validation Type Source
UNKNOWN Other UNKNOWN UNKNOWN miRTarBase
NCKAP1 hsa-let-7b-3p low: 0 high: 2 1 2 1 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Balakrishnan I et al. 2014 IP Bone Marrow HS5 N/A N/A
Location Method Result Regulation Validation Type Source
chr2:182925185-182925200 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Bone Marrow HS27A N/A N/A
Location Method Result Regulation Validation Type Source
chr2:182925018-182925024 HITS-CLIP POSITIVE DIRECT TarBase 7.0
FSCN1 hsa-let-7b-3p low: 0 high: 2 2 2 2 0.798
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr7:5606567-5606585 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Bone Marrow HS5 N/A N/A
Location Method Result Regulation Validation Type Source
chr7:5606567-5606585 HITS-CLIP POSITIVE DIRECT TarBase 7.0
PDS5B hsa-let-7b-3p low: 0 high: 2 2 2 2 0.991
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr13:32775337-32775358 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Bone Marrow HS5 N/A N/A
Location Method Result Regulation Validation Type Source
chr13:32775337-32775358 HITS-CLIP POSITIVE DIRECT TarBase 7.0
WAC hsa-let-7b-3p low: 0 high: 2 2 2 2 0.931
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr10:28620922-28620944 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Pillai MM et al. 2014 IP Mammary Gland BT474 N/A N/A
Location Method Result Regulation Validation Type Source
chr10:28620337-28620344 HITS-CLIP POSITIVE DIRECT TarBase 7.0
SOD2 hsa-let-7b-3p low: 0 high: 2 2 2 2 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Pillai MM et al. 2014 IP Mammary Gland BT474 N/A N/A
Location Method Result Regulation Validation Type Source
chr6:159681665-159681686 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Bone Marrow HS5 N/A N/A
Location Method Result Regulation Validation Type Source
chr6:159681122-159681143 HITS-CLIP POSITIVE DIRECT TarBase 7.0
ST8SIA4 hsa-let-7b-3p low: 0 high: 2 1 2 1 0.693
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Skalsky Rebecca L. et al. 2012 IP N/A LCLBAC N/A N/A
Location Method Result Regulation Validation Type Source
chr5:100811602-100811622 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Skalsky Rebecca L. et al. 2012 IP N/A LCLBACD1 N/A N/A
Location Method Result Regulation Validation Type Source
chr5:100811602-100811622 PAR-CLIP POSITIVE DIRECT TarBase 7.0
UBE3A hsa-let-7b-3p low: 0 high: 2 2 2 2 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr15:25371398-25371413 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Pillai MM et al. 2014 IP Mammary Gland BT474 N/A N/A
Location Method Result Regulation Validation Type Source
chr15:25356775-25356802 HITS-CLIP POSITIVE DIRECT TarBase 7.0
ACTR3 hsa-let-7b-3p low: 0 high: 2 1 2 1 0.913
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Balakrishnan I et al. 2014 IP Bone Marrow HS5 N/A N/A
Location Method Result Regulation Validation Type Source
chr2:113958452-113958459 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Bone Marrow HS27A N/A N/A
Location Method Result Regulation Validation Type Source
chr2:113958452-113958459 HITS-CLIP POSITIVE DIRECT TarBase 7.0
RAB14 hsa-let-7b-3p low: 0 high: 2 2 2 2 0.879
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Pillai MM et al. 2014 IP Mammary Gland BT474 N/A N/A
Location Method Result Regulation Validation Type Source
chr9:121179745-121179768 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Kameswaran V et al. 2014 IP Pancreas BETA Cells N/A N/A
Location Method Result Regulation Validation Type Source
chr9:121179745-121179768 HITS-CLIP POSITIVE DIRECT TarBase 7.0
RDH10 hsa-let-7b-3p low: 0 high: 2 2 2 2 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Pillai MM et al. 2014 IP Mammary Gland BT474 N/A N/A
Location Method Result Regulation Validation Type Source
chr8:73324397-73324403 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Bone Marrow HMSC N/A N/A
Location Method Result Regulation Validation Type Source
chr8:73324397-73324403 HITS-CLIP POSITIVE DIRECT TarBase 7.0
BTG1 hsa-let-7b-3p low: 0 high: 2 2 2 2 0.760
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr12:92143217-92143231 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Bone Marrow HS5 N/A N/A
Location Method Result Regulation Validation Type Source
chr12:92143588-92143605 HITS-CLIP POSITIVE DIRECT TarBase 7.0
PUM1 hsa-let-7b-3p low: 0 high: 2 2 2 2 0.956
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr1:30932106-30932131 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Pillai MM et al. 2014 IP Mammary Gland BT474 N/A N/A
Location Method Result Regulation Validation Type Source
chr1:30932963-30932984 HITS-CLIP POSITIVE DIRECT TarBase 7.0
DYNC1LI2 hsa-let-7b-3p low: 0 high: 2 2 2 2 0.767
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Pillai MM et al. 2014 IP Mammary Gland BT474 N/A N/A
Location Method Result Regulation Validation Type Source
chr16:66723675-66723681 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Bone Marrow HS5 N/A N/A
Location Method Result Regulation Validation Type Source
chr16:66723675-66723681 HITS-CLIP POSITIVE DIRECT TarBase 7.0
YAP1 hsa-let-7b-3p low: 0 high: 2 2 2 2 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Pillai MM et al. 2014 IP Mammary Gland BT474 N/A N/A
Location Method Result Regulation Validation Type Source
chr11:102231946-102231960 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Bone Marrow HS5 N/A N/A
Location Method Result Regulation Validation Type Source
chr11:102231946-102231960 HITS-CLIP POSITIVE DIRECT TarBase 7.0
THBS1 hsa-let-7b-3p low: 0 high: 2 2 2 2 0.515
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr15:39597393-39597410 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Bone Marrow HS5 N/A N/A
Location Method Result Regulation Validation Type Source
chr15:39597393-39597410 HITS-CLIP POSITIVE DIRECT TarBase 7.0